Oral Anticoagulation Reversal Learning Zone
Expert Insights
A small but notable number of patients receiving oral anticoagulation will experience a major bleed or require invasive surgery. In these situations, anticoagulation reversal is often essential, but how should reversal be managed in these patients? How should it differ between patients receiving a vitamin K antagonist (VKA), and a non-vitamin K antagonist oral anticoagulant (NOAC)?
Join Professor Donat Spahn, Professor Thorsten Steiner and Dr Oliver Grottke as they discuss best practice in the management of oral anticoagulation reversal.
Oral anticoagulation reversal roundtable discussion
Reversing warfarin part 1: plasma or PCC?
Reversing warfarin part 2: outcomes with PCCs
Reversal of NOACs part 1: direct factor Xa inhibitors
Reversal of NOACs part 2: direct factor IIa inhibitors
Recommendations for clinical practice - Case study 1
Recommendations for clinical practice - Case study 2
Anticoagulation and bleeding risk
When to reverse anticoagulation - Part 1
When to reverse anticoagulation - Part 2
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event
Job number: KCT16-01-0010
Developed by EPG Health for Medthority in collaboration with CSL Behring, with content provided by CSL Behring.
Not intended for Healthcare Professionals outside Europe.